The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
2023; Springer Nature; Volume: 37; Issue: 17 Linguagem: Inglês
10.1038/s41433-023-02553-5
ISSN1476-5454
AutoresArshad M. Khanani, Aamir Aziz, Hannah Khan, Ashwin Gupta, Ohidul Mojumder, Aigerim Saulebayeva, Ashkan M. Abbey, David R.P. Almeida, Robert L. Avery, Himanshu Banda, Mark Barakat, Ramanath Bhandari, Emmanuel Chang, Sara J. Haug, Nikolas London, Luke Mein, Veeral Sheth, Jeremy D. Wolfe, Michael Singer, Carl J. Danzig,
Tópico(s)Retinal and Optic Conditions
ResumoInvestigate real-world patients receiving faricimab for the treatment of neovascular age-related macular degeneration (nAMD).
Referência(s)